Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.79M | 5.76M | 4.93M | 4.94M | 5.34M |
Total Receivables | 5.67M | 5.64M | 3.86M | 3.87M | 977.20K |
Inventory | 6.28M | 6.25M | 5.67M | 5.68M | 5.49M |
Prepaid Expenses | 1.27M | 1.27M | 1.04M | 1.04M | 704.90K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 3.90K | 3.80K | 3.80K | 3.80K | -- |
Total Current Assets | 19.01M | 18.92M | 15.50M | 15.53M | 12.51M |
|
|||||
Total Current Assets | 19.01M | 18.92M | 15.50M | 15.53M | 12.51M |
Net Property, Plant & Equipment | 2.96M | 2.95M | 1.12M | 1.12M | 61.80K |
Long-term Investments | 6.22M | 6.19M | 6.18M | 6.19M | -- |
Goodwill | 6.22M | 6.19M | 6.18M | 6.19M | -- |
Total Other Intangibles | 851.30K | 847.10K | 938.70K | 940.40K | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.41M | 1.41M | 1.40M | 1.41M | -- |
Total Assets | 30.46M | 30.31M | 25.15M | 25.19M | 12.57M |
|
|||||
Total Accounts Payable | 1.07M | 1.06M | 1.01M | 1.01M | 483.60K |
Total Accrued Expenses | 722.80K | 719.20K | 537.20K | 538.20K | 762.00K |
Short-term Debt | 1.36M | 1.35M | 1.20M | 1.21M | 383.10K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 280.20K | 278.80K | 142.10K | 142.30K | 38.60K |
Total Finance Division Other Current Liabilities | 6.08M | 6.05M | 2.35M | 2.35M | 1.28M |
Total Other Current Liabilities | 6.08M | 6.05M | 2.35M | 2.35M | 1.28M |
Total Current Liabilities | 9.51M | 9.46M | 5.24M | 5.25M | 2.95M |
|
|||||
Total Current Liabilities | 9.51M | 9.46M | 5.24M | 5.25M | 2.95M |
Long-Term Debt | 5.12M | 5.09M | 5.07M | 5.08M | -- |
Short-term Debt | 1.36M | 1.35M | 1.20M | 1.21M | 383.10K |
Capital Leases | 1.70M | 1.69M | 121.10K | 121.40K | 10.70K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 306.20K | 304.70K | 301.10K | 301.60K | -- |
Total Liabilities | 16.64M | 16.55M | 10.73M | 10.75M | 2.96M |
|
|||||
Common Stock & APIC | 84.88M | 84.46M | 84.27M | 84.42M | 80.70M |
Retained Earnings | -72.81M | -72.45M | -71.49M | -71.62M | -71.80M |
Treasury Stock & Other | -917.60K | -913.00K | -469.50K | -470.30K | 713.10K |
Total Common Equity | 11.15M | 11.09M | 12.31M | 12.33M | 9.61M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 11.15M | 11.09M | 12.31M | 12.33M | 9.61M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 2.68M | 2.67M | 2.11M | 2.11M | -- |
Total Equity | 13.83M | 13.76M | 14.41M | 14.44M | 9.61M |
|